James Dundas-Grant
James Dundas-Grant (1866–1945) was a British otolaryngologist who made significant contributions to the field of otolaryngology. He was known for his work on diseases of the ear, nose, and throat, and his research has had a lasting impact on the medical community.
Early Life and Education[edit | edit source]
James Dundas-Grant was born in 1866 in London, England. He received his medical education at the University of London, where he graduated with a Bachelor of Medicine and Bachelor of Surgery degree. He later pursued further studies in otolaryngology, a specialty that focuses on the diagnosis and treatment of conditions affecting the ear, nose, and throat.
Career[edit | edit source]
Dundas-Grant began his career as a general practitioner but soon developed an interest in otolaryngology. He worked at several hospitals in London, including the Royal National Throat, Nose and Ear Hospital, where he served as a senior surgeon. He also held teaching positions at the University of London and the Royal College of Surgeons.
Throughout his career, Dundas-Grant published numerous articles and books on otolaryngology. His most notable work, "Diseases of the Nose and Throat," is still considered a seminal text in the field. He was also known for his innovative surgical techniques, many of which are still in use today.
Legacy[edit | edit source]
James Dundas-Grant's contributions to otolaryngology have had a lasting impact on the field. His research and surgical techniques have helped shape modern practices, and his writings continue to be a valuable resource for medical professionals.
See Also[edit | edit source]
- Otolaryngology
- University of London
- Royal National Throat, Nose and Ear Hospital
- Royal College of Surgeons
References[edit | edit source]
James Dundas-Grant Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD